I am currently a research fellow in the Department of Pharmacology and Therapeutics at the University of Liverpool. My research interests currently focus on the development and pharmacological assessment of novel long acting nanomedicines. I have gained substantial experience in in vitro, in vivo and in silico assessment of long acting nanoformulations. My research interests also focus on the disposition and interactions of drugs within the CNS. This includes investigating drug uptake and toxicity utilising in vitro cell systems, screening of genetic markers for increased disposition of drug induced CNS toxicity and in vivo disposition of standard and nanoformulated antiretrovirals. I have expertise in physiologically based pharmacokinetic (PBPK) modelling and have utilised this skill to predict plasma and tissue distribution of standard and long acting nanoformulations of antiretrovirals prior to animal and clinical studies.